A new international clinical trial led by the National Cancer Center Singapore is reporting that three years of aspirin ...

Gadoquatrane, a contrast agent Bayer is developing for use in MRI scans, like those done in MS, uses 60% less gadolinium and ...

Treating patients with aspirin after completion of standard adjuvant therapy for colorectal cancer failed to significantly ...

The pharmaceutical company’s latest partnership with Incremental and Skai drove a 32% boost in iROI, delivering nearly a ...

These launches are what Oelrich called “must-win battles” at Bayer as the Xarelto loss of exclusivity reaches “full swing” in ...